Silver Book Fact

Total medical costs for Afib patients over 15-month period

A study of Medicare beneficiaries with atrial fibrillation found that total medical costs for treating these patients during a 15-month follow-up period were an average of $24,000 per patient—63% of these costs were related to readmission.

Sullivan, E, S Braithwaite, K Dietz, and C Hickey. Health Services Utilization and Medical Costs Among Medicare Atrial Fibrillation Patients. Washington, DC: Avalere Health; 2010. http://www.avalerehealth.net/research/docs/Avalere-AFIB_Report-09212010.pdf

Reference

Title
Health Services Utilization and Medical Costs Among Medicare Atrial Fibrillation Patients
Publisher
Avalere Health
Publication Date
2010
Authors
Sullivan, E, S Braithwaite, K Dietz, and C Hickey.
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib prevalence estimates
    Atrial fibrillation is the most common heart arrhythmia in the U.S. Often going undiagnosed, AFib prevalence estimates vary between 2.7 million and 6.1 million Americans.  
  • AFib attributed stroke rate by age
    The percentage of strokes attributable to atrial fibrillation increases from 1.5% at ages 50 to 59, to 23.5% at ages 80 to 89.  
  • Risk of ischemic stroke in AFib patients
    The risk of ischemic stroke in nonvalvular atrial fibrillation patients is 2 to 7 times (200% to 700%) greater than in those without the disease.  
  • AFib rates by age
    Around 82% of Americans with atrial fibrillation are age 65 and older. Around 37% are age 80 and older.  
  • AFib prevalence as population ages
    As our population continues to age, prevalence of Afib is going to skyrocket, to a projected 5.6 to 15.9 million adults by 2050.